mouse antibodies against stat1 α (1:500) (Thermo Fisher)
Structured Review

Mouse Antibodies Against Stat1 α (1:500), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+antibodies+against+stat1+%CE%B1+%281%3A500%29/pmc04624297-386-0-12?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease"
Article Title: Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease
Journal: Journal of neurovirology
doi:
Figure Legend Snippet: Activation of kinases and transcription factors in CJD microglia. Representative western blots for IRF-3 (A), total and phosphorylated forms of the p44 and p42 MAP kinases (B), as well as phosphorylated STAT1 and total STAT1α (C). The phospho-STAT1 antibody recognizes both the STAT1α (p91) and STAT1β (p84) forms of the molecule, which are generated by alternative splicing. Normalization to α-tubulin protein was used to control for differences in protein loading on the blots. Equivalent levels of total p44/p42 MAP kinases and STAT1α in normal and CJD microglia confirm that any changes in the phosphospecific forms of these molecules are indeed the result of differential phosphorylation between these cell populations.
Techniques Used: Activation Assay, Western Blot, Generated
Figure Legend Snippet: Comparison of typical innate immune signaling cascades (top panel) with those activated by CJD infection (bottom panel). The pathway diagram has been adapted from Taniguchi and Takaoka (2002). Dotted lines indicate interactions that are indirect or hypothetical. Typical innate immune responses are initiated by recognition of certain foreign protein motifs, mediated by toll-like receptors (TLRs) or other molecules (at A). This leads to the activation of NFκB and IRF-3 transcription factors, which induce the expression of interferons, RANTES, ISG15, CXCL10, and other genes as part of a primary response (at B). Newly synthesized interferons (at C), acting through the type I interferon receptor (IFNAR1/2), activate the STAT1/STAT2/IRF-9 transcription factor complex and instigate two major effects. First, this complex amplifies the expression of some primary response genes (at D). Second, this complex stimulates the expression of a distinct set of transcripts, termed secondary response genes (at E). One of these secondary response genes, the IRF-7 transcription factor, augments transcription of type I interferons and thus completes a positive feedback loop in the innate immune response (at F). In comparison to nonspecific stimuli, the CJD agent does not appear to follow the same recognition pathway (G) leading to increased interferon transcription (H) or synthesis (I). The CJD agent instead elevates certain primary (J) and secondary (K) response genes in an interferon-independent manner, which may involve IRF family transcription factors. The induction of IRF-7 in CJD microglia in principle should result in positive feedback onto the IFNβ promoter (L), priming the cells to exhibit a potentiated response to a challenge stimulus such as poly I:C.
Techniques Used: Infection, Activation Assay, Expressing, Synthesized
Figure Legend Snippet: PCR conditions
Techniques Used: